Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-08-12
DOI
10.1093/eurheartj/ehaa697
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures
- (2020) Yixuan Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Single-cell RNA sequencing analysis reveals alginate oligosaccharides preventing chemotherapy-induced mucositis
- (2020) Yong Zhao et al. Mucosal Immunology
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?
- (2020) Camillo Sargiacomo et al. Aging-US
- COVID-19, ACE2, and the cardiovascular consequences
- (2020) Andrew M. South et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19
- (2020) Hin Chu et al. CLINICAL INFECTIOUS DISEASES
- Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors
- (2020) Iziah E Sama et al. EUROPEAN HEART JOURNAL
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
- (2020) Hao Cheng et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Spread of SARS-CoV-2 in the Icelandic Population
- (2020) Daniel F. Gudbjartsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Virology, Epidemiology, Pathogenesis, and Control of COVID-19
- (2020) Yuefei Jin et al. Viruses-Basel
- Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease
- (2018) Jay Ramchand et al. PLoS One
- A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
- (2017) Ziad Hijazi et al. EUROPEAN HEART JOURNAL
- Relationship between genetic variants of ACE2 gene and circulating levels of ACE2 and its metabolites
- (2017) Y. Y. Chen et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
- (2017) Daniel Lindholm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease
- (2016) Lidia Anguiano et al. ATHEROSCLEROSIS
- Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease
- (2016) Emil Hagström et al. CLINICAL CHEMISTRY
- Reference-based phasing using the Haplotype Reference Consortium panel
- (2016) Po-Ru Loh et al. NATURE GENETICS
- Second-generation PLINK: rising to the challenge of larger and richer datasets
- (2015) Christopher C Chang et al. GigaScience
- Efficient haplotype matching and storage using the positional Burrows-Wheeler transform (PBWT)
- (2014) R. Durbin BIOINFORMATICS
- Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation
- (2014) Lars Wallentin et al. CIRCULATION
- New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure
- (2014) Katalin Úri et al. PLoS One
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
- (2014) Erika Assarsson et al. PLoS One
- From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
- (2014) Sheila K. Patel et al. Frontiers in Physiology
- Angiotensin converting enzyme 2: A new important player in the regulation of glycemia
- (2013) Kavaljit H. Chhabra et al. IUBMB LIFE
- N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation
- (2013) Ziad Hijazi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
- (2013) A. Heurich et al. JOURNAL OF VIROLOGY
- GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
- (2013) Lars Wallentin et al. PLoS One
- Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation
- (2012) Ziad Hijazi et al. CIRCULATION
- Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study
- (2012) Fatimah S Dawood et al. LANCET INFECTIOUS DISEASES
- Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications
- (2011) Aino Soro-Paavonen et al. JOURNAL OF HYPERTENSION
- Epidemiology of 2009 Pandemic Influenza A (H1N1) Deaths in the United States, April-July 2009
- (2010) A. L. Fowlkes et al. CLINICAL INFECTIOUS DISEASES
- Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia
- (2009) Hong Peng Jia et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure
- (2008) Slava Epelman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
- (2008) Björn Zethelius et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now